{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:10:21Z","timestamp":1791090621217,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.ejphar.2007.11.065","type":"journal-article","created":{"date-parts":[[2008,1,21]],"date-time":"2008-01-21T12:31:31Z","timestamp":1200918691000},"page":"340-349","source":"Crossref","is-referenced-by-count":70,"title":["Involvement of vasopressin in affective disorders"],"prefix":"10.1016","volume":"583","author":[{"given":"Alexandre","family":"Surget","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Belzung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2007.11.065_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/frne.1994.1013","article-title":"Regulation of pituitary ACTH secretion during chronic stress","volume":"15","author":"Aguilera","year":"1994","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2007.11.065_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-0115(00)00196-8","article-title":"Vasopressinergic regulation of the hypothalamic\u2013pituitary\u2013adrenal axis: implications for stress adaptation","volume":"96","author":"Aguilera","year":"2000","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2007.11.065_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(00)00542-2","article-title":"Neuromodulation of memory in the hippocampus by vasopressin","volume":"405","author":"Alescio-Lautier","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.11.065_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.mp.4001464","article-title":"Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression","volume":"9","author":"Alonso","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.065_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0006-8993(92)91326-A","article-title":"Chronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro","volume":"593","author":"Altemus","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.11.065_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0031-9384(98)00119-X","article-title":"Vasopressin administration modulates anxiety-related behavior in rats","volume":"64","author":"Appenrodt","year":"1998","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2007.11.065_bib7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1176\/ajp.156.4.585","article-title":"Serial SF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder","volume":"156","author":"Baker","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.065_bib8","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1176\/appi.ajp.162.5.992","article-title":"Higher levels of basal serial CSF cortisol in combat veterans with posttraumatic stress disorder","volume":"162","author":"Baker","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.065_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1677\/joe.0.1560223","article-title":"Structural bases of vasopressin\/oxytocin receptor function","volume":"156","author":"Barberis","year":"1998","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2007.11.065_bib10","first-page":"59676","article-title":"Anxiety from a phylogenetic perspective: is there a qualitative difference between human and animal anxiety?","author":"Belzung","year":"2007","journal-title":"Neural. Plast."},{"key":"10.1016\/j.ejphar.2007.11.065_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0091-3057(87)90006-2","article-title":"Anxiogenic effects of methyl-\u03b2-carboline-3-carboxylate in a light\/dark choice situation","volume":"28","author":"Belzung","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2007.11.065_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/187152706776359682","article-title":"Neuropeptides in psychiatric diseases: an overview with a particular focus on depression and anxiety disorders","volume":"5","author":"Belzung","year":"2006","journal-title":"CNS Neurol. Disord. Drug. Targets"},{"key":"10.1016\/j.ejphar.2007.11.065_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.brainresprot.2004.03.003","article-title":"Long double-stranded RNA-mediated RNA interference as a tool to achieve site-specific silencing of hypothalamic neuropeptides","volume":"13","author":"Bhargava","year":"2004","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"10.1016\/j.ejphar.2007.11.065_bib14","first-page":"367","article-title":"Anxiogenic activity of intraventricularly administered arginine vasopressin in the rat","volume":"14","author":"Bhattacharya","year":"1998","journal-title":"Biog. Amines"},{"key":"10.1016\/j.ejphar.2007.11.065_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neuron.2005.06.031","article-title":"The V1a vasopressin receptor is necessary and sufficient for normal social recognition: a gene replacement study","volume":"47","author":"Bielsky","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2007.11.065_bib16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1210\/mend-1-8-555","article-title":"Phorbol ester-induced down-regulation of protein kinase C abolishes vasopressin-mediated responses in rat anterior pituitary cells","volume":"1","author":"Bilezikjian","year":"1987","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2007.11.065_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pbb.2004.10.024","article-title":"AVP V1b selective antagonist SSR149415 blocks aggressive behaviors in hamsters","volume":"80","author":"Blanchard","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2007.11.065_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0079-6123(08)61593-9","article-title":"The vasopressin deficient Brattleboro rats: a natural knockout model used in the search for CNS effects of vasopressin","volume":"119","author":"Bohus","year":"1998","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ejphar.2007.11.065_bib19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1176\/ajp.154.5.624","article-title":"Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder","volume":"154","author":"Bremner","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.065_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0924-977X(02)00071-8","article-title":"Vasopressin in CSF and plasma in depressed suicide attempters: preliminary results","volume":"12","author":"Brunner","year":"2002","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2007.11.065_bib21","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1210\/mend-3-12-1935","article-title":"Protein kinase C mediates the effect of vasopressin in pituitary corticotrophs","volume":"3","author":"Carvallo","year":"1989","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2007.11.065_bib22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.1083968","article-title":"Influence of life stress on depression: moderation in the 5-HTT gene","volume":"301","author":"Caspi","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2007.11.065_bib23","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1111\/j.1469-445X.2000.tb00003.x","article-title":"Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassays","volume":"85","author":"Chan","year":"2000","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ejphar.2007.11.065_bib24","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1210\/endo-110-6-2097","article-title":"Adrenocorticotropin, and corticosterone secretion in Brattleboro rats","volume":"110","author":"Conte-Devolx","year":"1982","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2007.11.065_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0006-8993(92)90552-K","article-title":"Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus","volume":"577","author":"de Goeij","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.11.065_bib26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jpsychires.2005.08.002","article-title":"Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests. A review","volume":"40","author":"de Kloet","year":"2006","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejphar.2007.11.065_bib27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jpsychires.2006.11.009","article-title":"Elevated plasma arginine vasopressin levels in veterans with posttraumatic stress disorder","volume":"42","author":"de Kloet","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejphar.2007.11.065_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/sj.npp.1300002","article-title":"Anxious-retarded depression: relation with plasma vasopressin and cortisol","volume":"28","author":"de Winter","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.11.065_bib29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1469-7580.2005.00443.x","article-title":"Anatomy of melancholia: focus on hypothalamic\u2013pituitary\u2013adrenal axis overactivity and the role of vasopressin","volume":"207","author":"Dinan","year":"2005","journal-title":"J. Anat."},{"key":"10.1016\/j.ejphar.2007.11.065_bib30","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1210\/jc.84.6.2238","article-title":"Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: evidence of enhanced vasopressinergic responsivity","volume":"84","author":"Dinan","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2007.11.065_bib31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.physbeh.2004.01.013","article-title":"Behaviour in the elevated plus-maze predicts coping after subchronic mild stress in mice","volume":"81","author":"Ducottet","year":"2004","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2007.11.065_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbr.2004.05.018","article-title":"Correlations between behaviours in the elevated plus-maze and sensitivity to unpredictable subchronic mild stress: evidence from inbred strains of mice","volume":"156","author":"Ducottet","year":"2005","journal-title":"Behav. Brain Res.,"},{"key":"10.1016\/j.ejphar.2007.11.065_bib33","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0278-5846(03)00051-4","article-title":"Effects of the selective non-peptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild depression in mice","volume":"27","author":"Ducottet","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.065_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-8993(00)02464-1","article-title":"A single social defeat experience selectively stimulates the release of oxytocin, but not vasopressin, within the septal brain area of male rats","volume":"872","author":"Ebner","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.11.065_bib35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.0953-816x.2001.01869.x","article-title":"Forced swimming triggers vasopressin release within the amygdala to modulate stress-coping strategies in rats","volume":"15","author":"Ebner","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.11.065_bib36","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/sj.npp.1300784","article-title":"Disruption of the prepulse inhibition of the startle reflex in vasopressin V1b receptor knockout mice: reversal by antipsychotic drugs","volume":"30","author":"Egashira","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.11.065_bib37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0149-7634(95)00059-3","article-title":"Behavioral consequences of intracerebral vasopressin and oxytocin: focus on learning and memory","volume":"20","author":"Engelmann","year":"1996","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2007.11.065_bib38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1365-2826.2000.00507.x","article-title":"Processing of frameshifted vasopressin precursors","volume":"12","author":"Evans","year":"2000","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2007.11.065_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0166-4328(98)00004-7","article-title":"Differential modulation of lateral septal vasopressin receptor blockade in spatial-learning, social recognition, and anxiety-related behaviors in rats","volume":"99","author":"Everts","year":"1999","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2007.11.065_bib40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2265.1993.tb00522.x","article-title":"Potentiation of the classic ovine corticotrophin releasing hormone stimulation test by the combined administration of small doses of lysine vasopressin","volume":"38","author":"Favrod-Coune","year":"1993","journal-title":"Clin. Endocrinol. (Oxf)."},{"key":"10.1016\/j.ejphar.2007.11.065_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pbb.2006.01.001","article-title":"Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior","volume":"83","author":"Ferris","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2007.11.065_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1677\/joe.0.1350037","article-title":"Atrial natriuretic peptide is involved in the ACTH response to stress and glucocorticoid negative feedback in the rat","volume":"135","author":"Fink","year":"1992","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2007.11.065_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(98)00041-2","article-title":"Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?","volume":"82","author":"Griebel","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.11.065_bib44","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1073\/pnas.092012099","article-title":"Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders","volume":"99","author":"Griebel","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2007.11.065_bib45","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2174\/1381612053764797","article-title":"Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders","volume":"11","author":"Griebel","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2007.11.065_bib46","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/sj.bjp.0706383","article-title":"Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b\/oxytocin receptor antagonist","volume":"146","author":"Griffante","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.11.065_bib47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1601-183X.2005.00119.x","article-title":"Association of vasopressin 1a receptor levels with a regulatory microsatellite and behaviour","volume":"4","author":"Hammock","year":"2005","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.ejphar.2007.11.065_bib48","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.pbb.2006.12.021","article-title":"Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression","volume":"86","author":"Hodgson","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2007.11.065_bib49","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2003.09.011","article-title":"Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders","volume":"24","author":"Holmes","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2007.11.065_bib50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","article-title":"The corticosteroid receptor hypothesis of depression","volume":"23","author":"Holsboer","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.11.065_bib51","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.pnpbp.2006.12.008","article-title":"An arginine vasopressin V1b antagonist, SSR149415 elicits antidepressant-like effects in an olfactory bulbectomy model","volume":"31","author":"Iijima","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.ejphar.2007.11.065_bib52","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0006-3223(97)00301-6","article-title":"Arginine vasopressin is associated with hypercortisolemia and suicide attempts in depression","volume":"42","author":"Inder","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.065_bib53","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0079-6123(08)60206-X","article-title":"Neurohypophyseal hormone receptor systems in brain and periphery","volume":"72","author":"Jard","year":"1987","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ejphar.2007.11.065_bib54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0893-133X(01)00351-7","article-title":"Vasopressin mediates the response of the combined dexamethasone\/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders","volume":"26","author":"Keck","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.11.065_bib55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.npp.1300040","article-title":"Reduction in hypothalamic vasopressinergic hyper-drive contributes to clinically relevant behavioural and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model","volume":"28","author":"Keck","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.11.065_bib56","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1176\/ajp.156.6.837","article-title":"Causal relationship between stressful life events and the onset of major depression","volume":"156","author":"Kendler","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.065_bib57","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/acta.0.1290489","article-title":"Vasopressin as a neuroendocrine regulator of anterior pituitary hormone secretion","volume":"129","author":"Kjaer","year":"1993","journal-title":"Acta Endocrinol. (Copenh)."},{"key":"10.1016\/j.ejphar.2007.11.065_bib58","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0079-6123(08)61586-1","article-title":"Coping with stress in rats and mice: differential peptidergic modulation of the amygdala-lateral septum complex","volume":"119","author":"Koolhaas","year":"1998","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ejphar.2007.11.065_bib59","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0079-6123(08)60200-9","article-title":"Neurohypophyseal hormones and behavior","volume":"72","author":"Kov\u00e1cs","year":"1987","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ejphar.2007.11.065_bib60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/187152706776359664","article-title":"The involvement of the vasopressin system in stress-related disorders","volume":"5","author":"Landgraf","year":"2006","journal-title":"CNS Neurol. Disord. Drug. Targets"},{"key":"10.1016\/j.ejphar.2007.11.065_bib61","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.yfrne.2004.05.001","article-title":"Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication","volume":"25","author":"Landgraf","year":"2004","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2007.11.065_bib62","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.15-06-04250.1995","article-title":"V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats","volume":"15","author":"Landgraf","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.11.065_bib63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0304-3940(96)13069-X","article-title":"Septal vasopressin modulates anxiety-related behaviour in rats","volume":"217","author":"Liebsch","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2007.11.065_bib64","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/sj.npp.1301036","article-title":"Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat","volume":"31","author":"Louis","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.11.065_bib65","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biopsych.2005.08.008","article-title":"Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects","volume":"59","author":"Merali","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.065_bib66","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.biopsych.2005.12.010","article-title":"Increased arginine vasopressin mRNA expression in the human hypothalamus in depression: a preliminary report","volume":"60","author":"Meynen","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.065_bib67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0376-6357(86)90069-0","article-title":"Does neophobia necessarily imply fear or anxiety?","volume":"42","author":"Misslin","year":"1986","journal-title":"Behav. Proc."},{"key":"10.1016\/j.ejphar.2007.11.065_bib68","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0376-6357(89)80010-5","article-title":"Behavioural validation of a light\/dark choice procedure for testing anti-anxiety agents","volume":"18","author":"Misslin","year":"1989","journal-title":"Behav. Proc."},{"key":"10.1016\/j.ejphar.2007.11.065_bib69","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0306-4522(03)00105-2","article-title":"Chronic stress attenuates glucocorticoid negative feedback: involvement of the prefrontal cortex and hippocampus","volume":"119","author":"Mizoguchi","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2007.11.065_bib70","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.yhbeh.2006.12.007","article-title":"Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats","volume":"51","author":"Mlynarik","year":"2007","journal-title":"Horm. Behav."},{"key":"10.1016\/j.ejphar.2007.11.065_bib71","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1523\/JNEUROSCI.1614-04.2004","article-title":"Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety","volume":"24","author":"Murgatroyd","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.11.065_bib72","first-page":"336","article-title":"The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions","volume":"1","author":"Nemeroff","year":"1996","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.065_bib73","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pbb.2005.07.021","article-title":"Antidepressant-like effects of the vasopressin V1b receptor antagonist SSR149415 in the Flinders Sensitive Line rat","volume":"82","author":"Overstreet","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2007.11.065_bib74","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/scnp.2001.19411","article-title":"Stress and affective disorders in humans","volume":"6","author":"Paykel","year":"2001","journal-title":"Semin. Clin. Neuropsychiatry."},{"key":"10.1016\/j.ejphar.2007.11.065_bib75","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0006-3223(98)00053-5","article-title":"Sodium lactate and hypertonic sodium chloride induce equivalent panic incidence, panic symptoms, and hypernatremia in panic disorder","volume":"44","author":"Peskind","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.065_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2826.1991.tb00231.x","article-title":"Pathways to the secretion of adrenocorticotropin: a view from the portal","volume":"3","author":"Plotsky","year":"1991","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2007.11.065_bib77","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbr.2004.04.008","article-title":"Alterations in sucrose consumption, physical state, body weight and memory induced by chronic unpredictable mild stress: comparison of three strains of mice","volume":"155","author":"Pothion","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2007.11.065_bib78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviours: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.11.065_bib79","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archpsyc.1996.01830020055007","article-title":"Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression","volume":"53","author":"Purba","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.065_bib80","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1365-2826.1995.tb00734.x","article-title":"Regulation of pituitary vasopressin V1b receptor mRNA during stress in the rat","volume":"7","author":"Rabadan-Diehl","year":"1995","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2007.11.065_bib81","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.yhbeh.2006.06.019","article-title":"Role of corticotropin releasing factor in anxiety disorders: a translational research perspective","volume":"50","author":"Risbrough","year":"2006","journal-title":"Horm. Behav."},{"key":"10.1016\/j.ejphar.2007.11.065_bib82","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0889-8529(05)70207-3","article-title":"Antidiuretic hormone. Normal and disordered function","volume":"30","author":"Robertson","year":"2001","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.ejphar.2007.11.065_bib83","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3940(82)90213-0","article-title":"Failure of vasopressin to enhance memory in a passive avoidance task in rats","volume":"28","author":"Sahgal","year":"1982","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2007.11.065_bib84","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00213-006-0424-1","article-title":"Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats","volume":"187","author":"Salom\u00e9","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2007.11.065_bib85","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/308705a0","article-title":"Single base deletion in the vasopressin gene is the cause of diabetes insipidus in Brattleboro rats","volume":"308","author":"Schmale","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2007.11.065_bib86","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1124\/jpet.300.3.1122","article-title":"Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist","volume":"300","author":"Serradeil-Le Gal","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.11.065_bib87","first-page":"53","article-title":"An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders","volume":"11","author":"Serradeil-Le Gal","year":"2005","journal-title":"C.N.S. Drug. Rev."},{"key":"10.1016\/j.ejphar.2007.11.065_bib88","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2006.06.032","article-title":"The pituitary mediates the anxiolytic-like effects of the vasopressin V1B receptor antagonist, SSR149415, in a social interaction test in rats","volume":"543","author":"Shimazaki","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.11.065_bib89","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.npp.1300562","article-title":"Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415","volume":"30","author":"Stemmelin","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.11.065_bib90","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.arr.2005.03.003","article-title":"The stress system in the human brain in depression and neurodegeneration","volume":"4","author":"Swaab","year":"2005","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejphar.2007.11.065_bib91","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0893-133X(97)00054-7","article-title":"Plasma levels of arginine vasopressin elevated in patients with major depression","volume":"17","author":"van Londen","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.11.065_bib92","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0006-3223(97)80433-7","article-title":"Plasma arginine vasopressin and motor activity in major depression","volume":"43","author":"van Londen","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.065_bib93","first-page":"25","article-title":"Hypothalamic oxytocin mRNA during development of the Brattleboro rat: comparison to vasopressin mRNA","volume":"7","author":"Van Tol","year":"1990","journal-title":"Neurosci. Res. Commun."},{"key":"10.1016\/j.ejphar.2007.11.065_bib94","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.mp.4001420","article-title":"A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression","volume":"9","author":"van West","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.065_bib95","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1126\/science.7455701","article-title":"Effects of vasopressin on human memory functions","volume":"211","author":"Weingartner","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2007.11.065_bib96","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/sj.mp.4001195","article-title":"Vasopressin V1b receptor knockout reduces aggressive behavior in male mice","volume":"7","author":"Wersinger","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.065_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1300290","article-title":"Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin","volume":"29","author":"Wigger","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.11.065_bib98","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000122269","article-title":"Decreased adrenal sensitivity to ACTH in the vasopressin-deficient (Brattleboro) rat","volume":"14","author":"Wiley","year":"1974","journal-title":"Neuroendocrinology"},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2007.11.065_bib99","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0196-9781(85)90013-0","article-title":"Altered emotionality of the vasopressin-deficient Brattleboro rat","volume":"6","author":"Williams","year":"1985","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2007.11.065_bib100","series-title":"Handbook of Depression and Anxiety","first-page":"291","article-title":"Animal models of depression","author":"Willner","year":"1992"},{"key":"10.1016\/j.ejphar.2007.11.065_bib101","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/365545a0","article-title":"A role for central vasopressin in pair bonding in monogamous prairie voles","volume":"365","author":"Winslow","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2007.11.065_bib102","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.1523\/JNEUROSCI.16-23-07725.1996","article-title":"Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: a novel mechanism of regulating adrenocorticotropic hormone secretion?","volume":"16","author":"Wotjak","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.11.065_bib103","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0306-4522(97)00683-0","article-title":"Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: new insights into the secretory capacities of peptidergic neurons","volume":"85","author":"Wotjak","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2007.11.065_bib104","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejphar.2005.03.029","article-title":"Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol","volume":"514","author":"Yalcin","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.11.065_bib105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0193-953X(02)00002-3","article-title":"Current status of cortisol findings in post-traumatic stress disorder","volume":"25","author":"Yehuda","year":"2002","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.ejphar.2007.11.065_bib106","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1037\/0735-7044.111.3.599","article-title":"Species differences in V1a receptor gene expression in monogamous and non-monogamous voles: behavioral consequences","volume":"111","author":"Young","year":"1997","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.ejphar.2007.11.065_bib107","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/23650","article-title":"Increased affiliative response to vasopressin in mice expressing the V1a receptor from a monogamous vole","volume":"400","author":"Young","year":"1999","journal-title":"Nature"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908000253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908000253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T23:08:56Z","timestamp":1684192136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908000253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":107,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0014299908000253"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.11.065","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}